NCT01414426 2021-01-14
Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions
University of Chicago
Phase 2 Completed
University of Chicago
British Columbia Cancer Agency
AIDS Malignancy Consortium
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center